| __timestamp | ACADIA Pharmaceuticals Inc. | Veracyte, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 60602000 | 16606000 |
| Thursday, January 1, 2015 | 76369000 | 21497000 |
| Friday, January 1, 2016 | 4406000 | 25462000 |
| Sunday, January 1, 2017 | 13060000 | 28195000 |
| Monday, January 1, 2018 | 18330000 | 33078000 |
| Tuesday, January 1, 2019 | 19598000 | 36523000 |
| Wednesday, January 1, 2020 | 20550000 | 41455000 |
| Friday, January 1, 2021 | 19141000 | 74400000 |
| Saturday, January 1, 2022 | 10166000 | 101582000 |
| Sunday, January 1, 2023 | 45731000 | 112903000 |
In pursuit of knowledge
In the ever-evolving landscape of biotechnology, understanding cost structures is pivotal. From 2014 to 2023, Veracyte, Inc. and ACADIA Pharmaceuticals Inc. have showcased intriguing trends in their cost of revenue. Veracyte, Inc. has seen a remarkable increase, with costs surging by approximately 580% over the decade, peaking in 2023. This growth reflects their expanding operations and market reach. In contrast, ACADIA Pharmaceuticals Inc. experienced a more volatile trajectory, with costs fluctuating significantly, culminating in a 24% decrease from their 2015 peak. This disparity highlights differing strategic approaches: Veracyte's steady expansion versus ACADIA's adaptive cost management. As the biotech sector continues to innovate, these insights into cost dynamics offer a glimpse into the financial strategies shaping the industry's future.
Cost of Revenue: Key Insights for Johnson & Johnson and Veracyte, Inc.
Cost Insights: Breaking Down Incyte Corporation and ACADIA Pharmaceuticals Inc.'s Expenses
BioMarin Pharmaceutical Inc. vs ACADIA Pharmaceuticals Inc.: Efficiency in Cost of Revenue Explored
Cost of Revenue: Key Insights for Sarepta Therapeutics, Inc. and ACADIA Pharmaceuticals Inc.
Cost of Revenue Comparison: Jazz Pharmaceuticals plc vs ACADIA Pharmaceuticals Inc.
Cost of Revenue Comparison: Halozyme Therapeutics, Inc. vs ACADIA Pharmaceuticals Inc.
Cost of Revenue Trends: Grifols, S.A. vs ACADIA Pharmaceuticals Inc.
Cost of Revenue Trends: Veracyte, Inc. vs Celldex Therapeutics, Inc.
Cost Insights: Breaking Down Veracyte, Inc. and Viridian Therapeutics, Inc.'s Expenses
Analyzing Cost of Revenue: ACADIA Pharmaceuticals Inc. and Vericel Corporation
ACADIA Pharmaceuticals Inc. vs Travere Therapeutics, Inc.: Efficiency in Cost of Revenue Explored
Cost of Revenue Trends: ACADIA Pharmaceuticals Inc. vs Evotec SE